Starbucks: Analysts Expect Q1 Revenues Of $7.95 Billion

Starbucks (NASDAQ: SBUX) will be reporting its first quarter financial results on February 1st before the market opens. Analysts have a consensus $121.97 12-month price target on the company, via a total of 37 analysts, with 9 analysts having strong buy ratings.

Nine analysts meanwhile have buy ratings, 18 analysts have a hold rating and a single analyst has a strong sell rating on the company. The street high comes from Kalinowski Equity Research with a $148 price target, and the lowest target sits at $96.

26 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 26 analysts is $7.95 billion; this number has been flat since October 30th. The highest revenue estimate is $8.18 billion, while the lowest is $7.4 billion.

Onto EBITDA estimates, there are currently 18 analysts who have first-quarter EBITDA estimates. The mean is currently $1.66 billion, with this number having been revised downwards from $1.71 billion at the end of October. The street high estimate currently sits at $1.82 billion in EBITDA and the lowest is $1.49 billion.

Analysts estimate that quarterly earnings per share will come in at $0.80, with this number flat since the end of October. The street high sits at $0.90 and the lowest estimate is $0.72 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Related News

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Sundial: “Limited Financial Synergies Arising From the [Inner Spirit] Transaction”

Sundial Growers Inc. (NASDAQ: SNDL) has had a somewhat busy M&A news week this week,...

Sunday, May 9, 2021, 04:41:00 PM

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221...

Sunday, March 14, 2021, 06:32:00 PM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

Stifel: “We View Green Thumb As The Best In Class Operator in US Cannabis”

Last week, Stifel GMP released their top picks for the fourth quarter of 2020, headlining...

Monday, October 19, 2020, 12:58:00 PM